Koshinski Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Koshinski Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.21M	Buy	+13,977	New	+$1.89M	0.12%	163
2022 Q2	–	Sell	-12	Closed	-$1.08K	–	1981
2022 Q1	$1.08K	Hold	12	–	–	﹤0.01%	2054
2021 Q4	$1.34K	Hold	12	–	–	﹤0.01%	2050
2021 Q3	$1.51K	Buy	+12	New	+$1.54K	﹤0.01%	2070
2021 Q1	–	Sell	-6,417	Closed	-$903K	–	644
2020 Q4	$903K	Sell	6,417 -71	-1%	-$9.09K	0.11%	207
2020 Q3	$782K	Buy	6,488 +364	+6%	+$40.8K	0.11%	214
2020 Q2	$686K	Buy	+6,124	New	+$603K	0.11%	217

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Koshinski Asset Management's XBI Position: Q2 2026 in Review

Koshinski Asset Management opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 13,977 shares worth $2.21M. The stake represents 0.12% of the portfolio and ranks #163 among its holdings. This is a return to the name: Koshinski Asset Management previously reported a position in XBI as recently as Q1 2022.

Koshinski Asset Management first reported a position in XBI in Q2 2020 and has held it in 7 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Koshinski Asset Management held 13,977 shares of State Street SPDR S&P Biotech ETF worth $2.21M as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Koshinski Asset Management position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.12% of Koshinski Asset Management's portfolio in Q2 2026, its #163 holding.
Koshinski Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 7 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.